Matinas Biopharma Holdings Stock Forecast

Sell candidate since Jun 18, 2026 Gain 6.71%

The Matinas Biopharma Holdings Inc stock price gained 2.16% on the last trading day (Thursday, 2nd Jul 2026), rising from $0.631 to $0.645. During the last trading day the stock fluctuated 8.69% from a day low at $0.616 to a day high of $0.669. The price has risen in 6 of the last 10 days but is still down by -9.23% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 33 thousand more shares were traded than the day before. In total, 55 thousand shares were bought and sold for approximately $35.26 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.619 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 27.91% during the next 3 months and, with a 90% probability hold a price between $0.791 and $1.21 at the end of this 3-month period.

MTNB Signals & Forecast

There are mixed signals in the stock today. The Matinas Biopharma Holdings Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.698. On a fall, the stock will find some support from the short-term average at $0.638. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -26.09%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Matinas Biopharma Holdings Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Matinas Biopharma Holdings Inc stock

Matinas Biopharma Holdings Inc finds support from accumulated volume at $0.638 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0535 between high and low, or 8.69%. For the last week, the stock has had daily average volatility of 6.67%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MTNB) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Matinas Biopharma Holdings Inc to open at $0.643, and during the day (based on 14 day Average True Range), to move between $0.613 and $0.676, which gives a possible trading interval of +/-$0.0639 (+/-10.42%) up or down from last closing price. If Matinas Biopharma Holdings Inc takes out the full calculated possible swing range there will be an estimated 10.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.638 (1.02%) than the resistance at $0.720 (11.71%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Matinas Biopharma Holdings Inc stock A Buy?

Matinas Biopharma Holdings Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.107 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $0.643 ( 0.233%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk